Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Wall Street Thinks Trumpflation Has Peaked, but There's an Unpleasant Surprise Looming for President Trump and Investors

The "Magnificent Seven" Ranked From Best to Worst Quarterly Performance -- and Which Ones Are the Best Buys Right Now

3 Magnificent Growth Stocks to Buy in July

VTI vs. IWM: Which Broad Index ETF Is the Better Buy?